Logan Capital Management Inc Laboratory Corp Of America Holdings Transaction History

Logan Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$213.32 - $257.83 $6,186 - $7,477	-29 Reduced 67.44%	14 $3,000
Q4 2022 Feb 14, 2023	BUY	$203.72 - $248.97 $5,907 - $7,220	29 Added 207.14%	43 $10,000
Q3 2022 Nov 14, 2022	SELL	$204.81 - $262.19 $9,216 - $11,798	-45 Reduced 76.27%	14 $3,000
Q4 2021 Feb 14, 2022	BUY	$271.6 - $314.21 $12,222 - $14,139	45 Added 321.43%	59 $19,000
Q2 2021 Aug 17, 2021	BUY	$251.87 - $278.14 $3,526 - $3,893	14 New	14 $4,000
Q2 2021 Aug 17, 2021	SELL	$251.87 - $278.14 $3,526 - $3,893	-14 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$204.88 - $255.03 $2,868 - $3,570	14 New	14 $4,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Logan Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Logan Capital Management Inc with notifications on news.